GenoSure Archive® uses next-generation sequencing (NGS)
GenoSure Archive® uses next-generation sequencing methods to provide a list of the archived mutations and then assigns susceptibility calls of "sensitive", "resistant", or "resistance possible" based on those mutations for nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), integrase inhibitors (INIs) and protease inhibitors (PIs). It can be useful when considering regimen changes due to: